The Choice Is Reperfusion Therapy: But Which One?
JACC Cardiovasc Interv
.
2016 Oct 10;9(19):2021-2023.
doi: 10.1016/j.jcin.2016.08.004.
Authors
Timothy D Henry
1
,
Paul W Armstrong
2
Affiliations
1
Cedars-Sinai Heart Institute, Los Angeles, California. Electronic address: henryt@cshs.org.
2
Canadian VIGOUR Centre, University of Alberta, Alberta, Edmonton, Alberta, Canada.
PMID:
27712738
DOI:
10.1016/j.jcin.2016.08.004
No abstract available
Keywords:
STEMI; fibrinolysis; pharmacoinvasive; primary PCI.
Publication types
Editorial
Comment
MeSH terms
Fibrinolytic Agents*
Myocardial Infarction
Myocardial Reperfusion
Thrombolytic Therapy*
Treatment Outcome
Substances
Fibrinolytic Agents